AURKA PHARMA
AurKa Pharma is a special purpose company created to develop one compound to proof-of-concept. To date, the biopharmaceutical asset has completed GLP toxicology studies.it plans to begin clinical development in Q3-2017. Once cleared for clinical development by regulatory authorities, the it compound will be tested directly alone in solid tumors. Later on, the compound may be tested in one of a number of additional cancer indications with the goal of providing a clinical proof-of-concept of efficacy for cancer patients.
AURKA PHARMA
Industry:
Biotechnology Medical Medical Device Pharmaceutical
Founded:
2016-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Total Employee:
11+
Status:
Active
Total Funding:
0
Current Employees Featured
Investors List
TVM Capital Life Science
TVM Capital Life Science investment in Venture Round - AurKa Pharma